ACE and Higher Education Groups Back Legal Challenge to NIH Grant Terminations
April 18, 2025

ACE and six other higher education associations filed an amicus brief Thursday supporting a legal challenge to the National Institutes of Health’s (NIH) sudden cancellation of research grants that it claims no longer align with the agency’s priorities.

Filed in Commonwealth of Massachusetts v. Kennedy—a case brought by 16 state attorneys general earlier this month— the brief forcefully opposes the unprecedented blacklisting of research perceived to be connected to politically disfavored topics, as well as the blatant illegality of terminating hundreds of existing awards without adequate explanation, notice, or adherence to legal process. The associations warn that these actions threaten to destabilize the entire biomedical research system.

In the brief, which was led by the Association of American Medical Colleges (AAMC) and submitted in the U.S. District Court for the District of Massachusetts, the associations underscore the severe consequences for institutions, researchers, and patients who participate in federally funded studies. 

The amicus brief details the critical importance of funding stability. For generations, higher education institutions and their medical schools, academic health systems, and teaching hospitals have relied on transparent and stable NIH grantmaking.

“Widespread termination of existing NIH awards would destroy the reliance interests at every level of the research enterprise,” the brief states, pointing to the significant investments colleges and universities make in research infrastructure and personnel, as well as the ethical commitments involved in clinical research.

The associations explain that abruptly terminating this research funding in areas ranging from HIV to vaccine hesitancy to gender identity without explanation violates the Administrative Procedure Act, which requires federal agencies to follow fair and transparent processes when making policy changes, including providing advance notice and a reasoned explanation. They also emphasize that the terminations violate NIH’s statutory obligations to fund research consistent with Congress’s funding authorizations, and without violating federal civil rights laws.  

In the wake of the cuts, longstanding research initiatives have been abruptly halted. The Adolescent Medicine Trials Network for HIV/AIDS Intervention—a 24-year program aimed at improving outcomes for young people—was terminated for being “based on … amorphous equity objectives,” cutting off participants’ access to life-saving medications. Grants for other programs were cut with no warning, including for suicide prevention efforts for high-risk youth, which led to “the immediate termination of services upon which lives depend,” according to the brief.

Even before the grant terminations, NIH had reported a significant decline in the number of postdoctoral scientists nationally. Institutions warn the current situation could accelerate the decline, as researchers consider leaving the field or moving abroad. The brief cites reporting in Science magazine warning that “[t]hese abrupt grant terminations could be a death knell to the academic careers of many promising scientists—a possibility that NIH failed to consider.” The article also suggests that NIH’s actions could prompt U.S.-based researchers to seek academic opportunities overseas or leave the scientific field altogethe.

The filing reflects a united stance from major higher education organizations concerned about the long-term effects of NIH’s actions.

“We cannot stand by and watch a partnership that the federal government and our research institutions maintained together for decades be incomprehensibly and illegally torn apart in weeks,” said Peter McDonough, ACE vice president and general counsel. “Approximately 80 percent of NIH’s annual budget supports the work of more than 300,000 people at over 2,500 institutions. It is the largest funder of health and medical research in the world. The impact of these grants cancelations would be devastating. Patients in clinical trials will die, promising research will stop, researchers will lose their jobs, and training the next generation of physicians and scientists will be derailed.”

Along with ACE, other groups joining the AAMC-led brief include the Association of American Universities, the Association of Public and Land-grant Universities, the American Association of State Colleges and Universities, the National Association of Independent Colleges and Universities, the Association of Governing Boards of Universities and Colleges, and COGR. Together, the organizations represent thousands of U.S. colleges, universities, and medical centers that conduct the majority of NIH-supported research.

A preliminary injunction hearing is scheduled for April 28.